HRP20020362A2 - Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prohylaxis of disease states as a result of ischaemic conditions - Google Patents

Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prohylaxis of disease states as a result of ischaemic conditions Download PDF

Info

Publication number
HRP20020362A2
HRP20020362A2 HR20020362A HRP20020362A HRP20020362A2 HR P20020362 A2 HRP20020362 A2 HR P20020362A2 HR 20020362 A HR20020362 A HR 20020362A HR P20020362 A HRP20020362 A HR P20020362A HR P20020362 A2 HRP20020362 A2 HR P20020362A2
Authority
HR
Croatia
Prior art keywords
production
treatment
compound
prophylaxis
phenyl
Prior art date
Application number
HR20020362A
Other languages
English (en)
Croatian (hr)
Inventor
Andreas Weichert
Udo Albus
Hans-Willi Jansen
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of HRP20020362A2 publication Critical patent/HRP20020362A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20020362A 1999-10-27 2000-10-14 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prohylaxis of disease states as a result of ischaemic conditions HRP20020362A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951701A DE19951701A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
PCT/EP2000/010126 WO2001030327A2 (de) 1999-10-27 2000-10-14 Verwendung von 2-imidazolyl-substituierten carbinolen zur herstellung eines medikaments zur behandlung oder prophylaxe von durch ischämischen zuständen

Publications (1)

Publication Number Publication Date
HRP20020362A2 true HRP20020362A2 (en) 2004-02-29

Family

ID=7927020

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020362A HRP20020362A2 (en) 1999-10-27 2000-10-14 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prohylaxis of disease states as a result of ischaemic conditions

Country Status (30)

Country Link
US (1) US6291502B1 (cs)
EP (1) EP1227811B1 (cs)
JP (1) JP2003512419A (cs)
KR (1) KR20020060213A (cs)
CN (1) CN1188125C (cs)
AR (1) AR026241A1 (cs)
AT (1) ATE257702T1 (cs)
AU (1) AU778836B2 (cs)
BR (1) BR0015024A (cs)
CA (1) CA2388956A1 (cs)
CZ (1) CZ295925B6 (cs)
DE (2) DE19951701A1 (cs)
DK (1) DK1227811T3 (cs)
EE (1) EE200200218A (cs)
ES (1) ES2213621T3 (cs)
HK (1) HK1048938B (cs)
HR (1) HRP20020362A2 (cs)
HU (1) HUP0203213A3 (cs)
IL (1) IL149208A0 (cs)
NO (1) NO20021909L (cs)
NZ (1) NZ518586A (cs)
PL (1) PL355911A1 (cs)
PT (1) PT1227811E (cs)
RU (1) RU2257205C2 (cs)
SK (1) SK5512002A3 (cs)
TR (1) TR200201140T2 (cs)
TW (1) TWI246424B (cs)
WO (1) WO2001030327A2 (cs)
YU (1) YU20902A (cs)
ZA (1) ZA200203035B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726829B2 (en) * 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
AU2003201273A1 (en) 2002-01-04 2003-07-30 Poseidon Pharmaceuticals A/S Potassium channel modulators
AR049847A1 (es) * 2004-07-29 2006-09-06 Merck & Co Inc Inhibidores de los canales de potasio
RU2373934C1 (ru) * 2008-03-19 2009-11-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
US10040767B2 (en) 2014-05-15 2018-08-07 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
US4152441A (en) 1972-02-04 1979-05-01 Gist-Brocades N.V. Analgesic imidazolemethanols
BE794940A (fr) * 1972-02-04 1973-08-02 Gist Brocades Nv Nouveaux composes anorexigenes
US5063220A (en) * 1988-10-21 1991-11-05 Syntex Pharmaceuticals, Ltd. Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6175013B1 (en) * 1994-06-10 2001-01-16 Eli Lilly And Company Imidazolinyl tachykinin receptor antagonists
SK282769B6 (sk) 1996-06-27 2002-12-03 Janssen Pharmaceutica N. V. N-[4-(Heteroarylmetyl)fenyl]heteroarylamín, spôsob jeho výroby a použitia, kompozícia na jeho báze

Also Published As

Publication number Publication date
SK5512002A3 (en) 2002-08-06
HK1048938A1 (en) 2003-04-25
TR200201140T2 (tr) 2002-11-21
WO2001030327A3 (de) 2002-03-14
EP1227811A2 (de) 2002-08-07
ATE257702T1 (de) 2004-01-15
PT1227811E (pt) 2004-05-31
AU778836B2 (en) 2004-12-23
ZA200203035B (en) 2003-03-14
CZ295925B6 (cs) 2005-11-16
CA2388956A1 (en) 2001-05-03
NO20021909D0 (no) 2002-04-23
DE19951701A1 (de) 2001-05-03
EP1227811B1 (de) 2004-01-14
US6291502B1 (en) 2001-09-18
CN1373663A (zh) 2002-10-09
BR0015024A (pt) 2002-06-18
RU2002113666A (ru) 2004-01-10
CN1188125C (zh) 2005-02-09
HUP0203213A3 (en) 2003-07-28
DK1227811T3 (da) 2004-04-19
AR026241A1 (es) 2003-02-05
EE200200218A (et) 2003-06-16
NZ518586A (en) 2004-07-30
IL149208A0 (en) 2002-11-10
JP2003512419A (ja) 2003-04-02
NO20021909L (no) 2002-04-23
HUP0203213A2 (en) 2003-05-28
RU2257205C2 (ru) 2005-07-27
CZ20021452A3 (cs) 2002-07-17
AU1138201A (en) 2001-05-08
WO2001030327A2 (de) 2001-05-03
KR20020060213A (ko) 2002-07-16
HK1048938B (zh) 2005-06-10
DE50005040D1 (de) 2004-02-19
TWI246424B (en) 2006-01-01
PL355911A1 (en) 2004-05-31
ES2213621T3 (es) 2004-09-01
YU20902A (sh) 2004-11-25

Similar Documents

Publication Publication Date Title
RU2336870C2 (ru) Применение l-бутилфталида для изготовления лекарственного средства для профилактики и лечения церебрального инфаркта
AU1797700A (en) Novel ligands of nuclear receptor
HRP960230A2 (en) Fluorophenyl substituted alkenyl carboxylic acid guanidines, processes for their preparation, their use as medicinal or diagnostic agent as well as medicaments containing them
WO2016172205A1 (en) Managing ebola viral infections
HRP20020362A2 (en) Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prohylaxis of disease states as a result of ischaemic conditions
JP2002527383A (ja) ヒストクロム、並びに急性心筋梗塞及び虚血性心疾患治療におけるその使用
HRP20020363A2 (en) Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
US11602519B1 (en) Method for preventing myocardial infarction using eucalyptol
JPS6245525A (ja) 脂質低下剤
HRP970101A2 (en) Ortho-substituted benzoylguanidines, process for their preparation and their use as medicament or diagnostic agent as well as medicaments containing them
JPH0212932B2 (cs)
US4159334A (en) Medicinal preparation with an antiinflammatory, analgesic and antipyretic effect
Striebel 4-Isothiocyanato-4′-Nitrodiphenylamine (C 9333-Go/CGP 4540), an Antischistosomal Compound with an Unusual Spectrum of Anthelminthic Activity Against Intestinal Nematodes, Filariae and Trematodes
CN115634228A (zh) 嘌呤合成抑制剂在制备治疗缺血和缺血再灌注损伤药物中的应用
TW201100078A (en) Pharmaceutical composition for the treatment and prophylaxis of a disorder induced from myocardial ischemia
US20070293459A1 (en) Method for Inhibiting Cellular Na+-K+ ATPase Activity
TWI393562B (zh) 左旋丁基苯酞在製備預防和治療腦梗塞的藥物中的應用
JPS5942377A (ja) ジチオ−ル誘導体
JPH03364B2 (cs)
EP1161242A1 (en) Composition and method for treating diabetes
HK1011985A (en) Substituted cyclohexanol esters, their use for treating diseases and pharmaceutical preparations

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
OBST Application withdrawn